CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Bridgeway Care Ctr

Bridgeway Care Ctr is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community First Health Plans

CFHP was established in 1995, by the University Health System, specifically to begin providing health care coverage to the citizens of Bexar and the surrounding seven counties. As the only locally owned and managed, non-profit health plan in the area,

PureLine Genetics

PureLine Genetics is a Preston, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Resources Network

Medical Resources Network is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioRealty

BioRealty, Inc. is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.